Abstract
Adherence to treatment is a major determinant of outcome in bipolar disorder. Poor insight, attitudes towards treatment, and poor understanding of medications and the illness can all lead to reduced adherence. Nonadherence and partial adherence both also appear to play a significant role in relapse and recurrence. Clinicians can address the problem of poor adherence by ensuring medication administration. Assured administration can be accomplished with long-acting atypical antipsychotic medications. Case series and naturalistic trials utilizing first generation antipsychotics suggest that depot antipsychotics are effective in reducing relapse in bipolar illness. Controlled studies with second generation agents confirm this impression. Depot antipsychotics, including long-acting first- and second-generation agents, can be important adjuncts in the long-term management of bipolar illness.
Keywords: Antipsychotic medications, Assured administration, Bipolar disorder, Depot, Intramuscular injection.
Current Drug Delivery
Title:Adherence and Assured Administration of Medications in Bipolar Patients
Volume: 10 Issue: 6
Author(s): Peggy L. El-Mallakh and Rif S. El-Mallakh
Affiliation:
Keywords: Antipsychotic medications, Assured administration, Bipolar disorder, Depot, Intramuscular injection.
Abstract: Adherence to treatment is a major determinant of outcome in bipolar disorder. Poor insight, attitudes towards treatment, and poor understanding of medications and the illness can all lead to reduced adherence. Nonadherence and partial adherence both also appear to play a significant role in relapse and recurrence. Clinicians can address the problem of poor adherence by ensuring medication administration. Assured administration can be accomplished with long-acting atypical antipsychotic medications. Case series and naturalistic trials utilizing first generation antipsychotics suggest that depot antipsychotics are effective in reducing relapse in bipolar illness. Controlled studies with second generation agents confirm this impression. Depot antipsychotics, including long-acting first- and second-generation agents, can be important adjuncts in the long-term management of bipolar illness.
Export Options
About this article
Cite this article as:
El-Mallakh L. Peggy and El-Mallakh S. Rif, Adherence and Assured Administration of Medications in Bipolar Patients, Current Drug Delivery 2013; 10 (6) . https://dx.doi.org/10.2174/156720181006131125152802
DOI https://dx.doi.org/10.2174/156720181006131125152802 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens
Current Drug Safety The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Current Drug Therapy The Role of Nutrition During the COVID-19 Pandemic: What We Know
Endocrine, Metabolic & Immune Disorders - Drug Targets Treatment of Chronic Migraine with Intramuscular Pericranial Injections of Onabotulinumtoxin A
Recent Patents on CNS Drug Discovery (Discontinued) β-Secretase as a Therapeutic Target for Inhibitor Drugs
Current Medicinal Chemistry Regulation of Mitochondrial Function and its Impact in Metabolic Stress
Current Medicinal Chemistry The Human Genome Puzzle — the Role of Copy Number Variation in Somatic Mosaicism
Current Genomics Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Current Pharmaceutical Design Photosensitizers Mediated Photodynamic Inactivation Against Virus Particles
Mini-Reviews in Medicinal Chemistry Cerebrovascular Amyloidosis and Dementia
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets The Enzymology of Cytosolic Pyrimidine 5’-Nucleotidases: Functional Analysis and Physiopathological Implications.
Current Medicinal Chemistry Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis
Current Topics in Medicinal Chemistry Bioproducts from Seaweeds: A Review with Special Focus on the Iberian Peninsula
Current Organic Chemistry Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism A Comprehensive Review of Poorly Differentiated Neuroendocrine Carcinomas (pdNECs): a Niche to Find Novel Opportunities
Current Pharmaceutical Design Effects of Metformin-Single Therapy on the Level of Inflammatory Markers in Serum of Non-Obese T2DM Patients with NAFLD
Endocrine, Metabolic & Immune Disorders - Drug Targets Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
Current Alzheimer Research Chromosomal Translocations in Hematologic Malignancies
Current Genomics